Christian Tharp was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick.
Christian Tharp, biotech expert and author of Five Star Stock Watch, discussed a few stocks, including Biogen Inc BIIB, which recently experienced a big selloff, and returned to trading above $300 on Monday.
Related Link: The Historical Correlation Between Biotech Stocks And Interest Rates
Tharp started by saying he likes to see Biogen trading once again above $300, which he conceives as a key level. In fact, when the stock plummeted in July, the $300-$320 lines lingered for about two weeks in the charts.
Moreover, he sees “a nice little trade from $300 to $320, tops.” However, a “push back below $300, I would say would probably send the stock back to new lows.”
Shares of Biogen closed down by 1.4 percent at $292.98 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.